Boston Scientific Corp.’s OPTION study demonstrated left atrial appendage closure with the Watchman Flx device reduced risk of stroke compared to management with direct oral anticoagulants or warfarin ...

Left atrial appendage closure is an alternative strategy for stroke prophylaxis, Wazni and colleagues noted. "The safety and ...

Boston Scientific (NYSE:BSX) announced positive three-year primary endpoint results from a clinical trial of its Watchman FLX ...

The trial met its primary safety and efficacy endpoints, demonstrating the device's superiority to oral anticoagulants.

Left atrial appendage occlusion (LAAO) appears to be a viable alternative to oral anticoagulation for stroke prevention in select patients undergoing catheter ablation for atrial fibrillation (AF), ...

In the corresponding quarter of the previous fiscal, LT Foods posted a net profit of ₹157.3 crore, the company said in a regulatory filing. The company's revenue from operations increased 6.6% to ...

The incidence of atrial fibrillation (AF) is on the rise, and recent joint guidelines from the American College of Cardiology and American Heart Association (ACC/AHA) stress the role of primary ...

Next-generation system to be highlighted during a technology innovation session and live case presentation by Professor Jens Erik Nielsen-Kudsk "We are pleased that the CLAAS AcuFORM system is ...

Harbaugh revealed in Week 6 that he is dealing with atrial flutter, a type of heart rhythm disorder. It can cause the heart to beat at an abnormally high rate. A flare-up caused him to seek ...